{"domain":"evkeezahcp.com","status":"valid","tier":"listed","authority":46,"verified":false,"title":"EVKEEZA (evinacumab-dgnb) Injection","summary":"EVKEEZA is an angiopoietin-like 3 (ANGPTL3) inhibitor indicated as an adjunct to diet and exercise and other low-density lipoprotein-cholesterol (LDL-C) lowering therapies to reduce LDL-C in adults and pediatric patients, aged 1 year and older, with homozygous familial hypercholesterolemia (HoFH). See Important Safety Information & full Prescribing Information on site.","country":null,"country_source":"cdn","publisher_country":null,"publisher_country_source":null,"hosting_country":null,"llms_txt":"https://www.evkeezahcp.com/llms.txt","llms_full_txt":null,"last_checked":"2026-10-23T13:45:36.999Z","agent_terms":null,"categories":["healthcare"],"capabilities":[],"inferred_tags":["evinacumab","homozygous familial hypercholesterolemia","ldl-c lowering","angptl3 inhibitor","prescribing information"],"audience":"mixed","agent_uses":["read_docs"],"language":"en","platform_generated":false,"agent_summary":"Product site for EVKEEZA (evinacumab-dgnb), an ANGPTL3 inhibitor for LDL-C lowering in HoFH patients aged 1 year and older; includes safety and prescribing info","llms_txt_cached":"https://agentwebmap.com/v1/domain/evkeezahcp.com/llms.txt","agentic":"documentation","section_keys":["additional-information","important-resources","important-safety-information","indication"],"section_partial":false,"section_indexed_at":"2026-10-23T13:45:40.463Z"}